Bindya S Singh, MD, FAAP
Neonatal-Perinatal Medicine · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Singh’s office at (408) 926-9600 to ask if they take your plan before you enroll.
California Medical Board record
Licence A68356 · Current
Licensed to practise in California · since 1999 · expires 2028-07-31 · University of Delhi, Lady Hardinge Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$1,703 in 2023
Medicaid paid $1,703 for 528 billed services this clinician did in 2023, up to 30 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Screening test, pure tone, air only | 136 | $1,227 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 64 | $476 |
| Return visit (30+ min) | 143 | $0 |
| Screening performed and negative | 185 | $0 |
| 2023 | 528 | 4 | 30 | $1,703 |
| 2022 | 967 | 7 | 41 | $8,879 |
| 2021 | 888 | 11 | 43 | $14,944 |
| 2020 | 632 | 7 | 38 | $7,376 |
| 2019 | 2,006 | 14 | 59 | $28,060 |
| 2018 | 1,699 | 11 | 90 | $16,292 |
See the largest Medicaid services in earlier years
2022
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 63 | $2,781 |
| Screening test, pure tone, air only | 269 | $2,366 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 43 | $1,740 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 145 | $1,170 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; second dose | 18 | $720 |
| Return visit (30+ min) | 200 | $103 |
| Screening performed and negative | 229 | $0 |
2021
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 129 | $5,864 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 86 | $3,432 |
| Screening test, pure tone, air only | 320 | $3,027 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 177 | $1,409 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; first dose | 18 | $720 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 12 | $330 |
| Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), 2 dose schedule, for intramuscular use | 12 | $89 |
| Skin test; tuberculosis, intradermal | 26 | $74 |
| OFF/OP EST MAY X REQ PHY/QHP | 19 | $0 |
| Short return visit (20+ min) | 57 | $0 |
| Return visit (30+ min) | 32 | $0 |
2020
| Screening test, pure tone, air only | 271 | $2,655 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 44 | $1,740 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 136 | $1,104 |
| LIMITED VISUAL FIELD XM UNI/BI I&R | 31 | $1,090 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 15 | $786 |
| Short return visit (20+ min) | 63 | $0 |
| Return visit (30+ min) | 72 | $0 |
2019
| LIMITED VISUAL FIELD XM UNI/BI I&R | 209 | $7,193 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 136 | $5,258 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 96 | $4,907 |
| Screening test, pure tone, air only | 408 | $3,840 |
| Developmental screening | 55 | $2,840 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 199 | $1,598 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 26 | $824 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 85 | $595 |
| Short return visit (20+ min) | 572 | $420 |
| Return visit (30+ min) | 101 | $308 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 25 | $169 |
| Skin test; tuberculosis, intradermal | 43 | $107 |
2018
| LIMITED VISUAL FIELD XM UNI/BI I&R | 157 | $4,934 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 89 | $3,867 |
| Pure tone audiometry (threshold); air only | 194 | $3,168 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 197 | $1,766 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 30 | $1,572 |
| Screening test, pure tone, air only | 51 | $490 |
| Skin test; tuberculosis, intradermal | 136 | $396 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 12 | $99 |
| OFF/OP EST MAY X REQ PHY/QHP | 97 | $0 |
| Short return visit (20+ min) | 280 | $0 |
| Return visit (30+ min) | 456 | $0 |
Professional record
- NPI
- 1912951880
- Licence
- CA A68356California A68356: Current · expires 2028-07-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2080N0001X (2080N0001X)
- Mailing address
- 135 N Jackson Ave, San Jose, CA, 95116
- NPI first listed
- 2006-05-22
- NPI last updated
- 2016-04-19
This is when the NPI record was last certified, not a medical board exam.